MIF and telomere syndrome: Although MIF- or SCD1 inhibition has not been reported in the case of STS, and our assay is insufficient to show the effects of MIF- or SCD1-inhibition for STS, many previous studies have suggested that MIF and SCD1 are potential therapeutic targets in the treatment of STS patients.